Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
Holders of 5% or more of SGMOQ
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sangamo Therapeutics, Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G/A | 9.38%38.9M shares | −0.37 ppfrom 9.75% | May 15, 20262 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
27 Schedule 13D and 13G filings on Sangamo Therapeutics, Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:26 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.38%38.9M shares | −0.37 ppfrom 9.75% | Jun 30, 2026 | SEC |
| May 15, 202611:27 AM ET | Armistice Capital, LLCand 1 other | 13G | 9.75%40.4M shares | New | Mar 31, 2026 | SEC |
| Nov 12, 20252:34 PM ET | Wasatch Advisors Inc | 13G/A | 2.10%6.19M shares | −3.10 ppfrom 5.20%Below 5% | Sep 30, 2025 | SEC |
| May 12, 20255:32 PM ET | Wasatch Advisors Inc | 13G/A | 5.20%11.6M shares | −1.40 ppfrom 6.60% | Mar 31, 2025 | SEC |
| Jan 7, 20256:47 PM ET | Wasatch Advisors Inc | 13G/A | 6.60%14.0M shares | – | Dec 31, 2024 | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Aug 16, 20246:40 PM ET | Biogen Inc. | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20244:32 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Apr 5, 2024 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 12, 20247:11 PM ET | Biogen Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 202411:49 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 22, 2024 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Oct 10, 2023 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2023 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Jan 24, 20231:56 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20225:08 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20218:23 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sangamo Therapeutics, Inc shares.
No Form 144 notices for Sangamo Therapeutics, Inc are on file.